Solid Biosciences Inc. (SLDB) Free cash flow 2016–2025
Solid Biosciences Inc. (SLDB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$157.4MFY2025 · since FY2016: -$20.5M → -$157.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$157.4M | -56.4% |
| FY2024 | -$100.7M | -5.2% |
| FY2023 | -$95.7M | +5.2% |
| FY2022 | -$101.0M | -27.8% |
| FY2021 | -$79.0M | -37.5% |
| FY2020 | -$57.5M | +40.8% |
| FY2019 | -$97.1M | -24.5% |
| FY2018 | -$78.0M | -71.4% |
| FY2017 | -$45.5M | -121.8% |
| FY2016 | -$20.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice